CG MedTech

시지메드텍 · 056090

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$102.9M (₩142B)

Overview

CG MedTech makes surgical implants and devices used in orthopaedic and spinal procedures, including spinal fixation systems, fracture-treatment devices, minimally invasive surgical tools, dental implants, and bone-graft biologics, supplied to hospitals and clinics.

It is listed on KOSDAQ, South Korea's tech and small-cap exchange. The company operates two distinct divisions: a medical-devices business and an electric-energy business that supplies electricity meters, heat-energy meters, electric-vehicle charging equipment, and related testing instruments, partly through government-led smart-grid and renewable-energy projects.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$34.2M

▲ +36.4% YoY

Operating profit · FY2025

US$2.8M

Turned profitable

Net income · FY2025

US$4.7M

Turned profitable

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$25.3M(₩35B)	US$25.1M(₩34.6B)	US$34.2M(₩47.2B)
Operating profit	−US$1.2M(−₩1.6B)	−US$808.9K(−₩1.1B)	US$2.8M(₩3.8B)
Net income	US$946.1K(₩1.3B)	−US$90.5K(−₩124.9M)	US$4.7M(₩6.5B)

Revenue

FY2023US$25.3M
FY2024US$25.1M
FY2025US$34.2M

Operating profit

FY2023−US$1.2M
FY2024−US$808.9K
FY2025US$2.8M

Net income

FY2023US$946.1K
FY2024−US$90.5K
FY2025US$4.7M

Key ratios (FY2025)

ROE

6.9%

Debt/Eq

22.1%

Op. margin

8.1%

Net margin

13.8%

Rev. YoY

▲ +36.4%

Why it matters

CG MedTech expanded into dental implants through the acquisitions of GDS, All Abutment, and Dental Ocean, and into the electric-energy sector through the acquisitions of DM Power and Infinity Works.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?